{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:14:28Z","timestamp":1783743268177,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pbb.2026.174218","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:15:50Z","timestamp":1780067750000},"page":"174218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of compulsive behavior by dextromethorphan on schedule-induced polydipsia in rats: Role of NMDA, sigma-1, and 5-HT receptors"],"prefix":"10.1016","volume":"266","author":[{"given":"Madeline T.","family":"Van Fossen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia G.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Prus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pbb.2026.174218_bb0005","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40263-023-01032-5","article-title":"Dextromethorphan-bupropion for the treatment of depression: a systematic review of efficacy and safety in clinical trials","volume":"37","author":"Akbar","year":"2023","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.pbb.2026.174218_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/WNF.0000000000000578","article-title":"Esketamine augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective chart review","volume":"47","author":"Alves-Pereira","year":"2024","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pbb.2026.174218_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cpr.2015.03.002","article-title":"Suicidality in obsessive compulsive disorder (OCD): A systematic review and meta-analysis","volume":"39","author":"Angelakis","year":"2015","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.pbb.2026.174218_bb1025","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1348551","article-title":"The impact of estradiol on serotonin, glutamate, and dopamine systems","volume":"18","author":"Bendis","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pbb.2026.174218_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.conb.2014.08.008","article-title":"Striatal circuits, habits, and implications for obsessive-compulsive disorder","volume":"30","author":"Burgui\u00e8re","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pbb.2026.174218_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.52963","article-title":"Glutamatergic medications for obsessive-compulsive and related disorders: a systematic review and meta-analysis","volume":"8","author":"Coelho","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.pbb.2026.174218_bb0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0091-3057(94)90134-1","article-title":"Corticotropin-releasing factor and schedule-induced polydipsia","volume":"47","author":"Cole","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.pbb.2026.174218_bb0040","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s11126-021-09892-0","article-title":"A Comparative Study of Aripiprazole, Olanzapine, and L-Methylfolate Augmentation in Treatment Resistant Obsessive-Compulsive Disorder","volume":"92","author":"Dar","year":"2021","journal-title":"Psychiatry Q."},{"issue":"5","key":"10.1016\/j.pbb.2026.174218_bb0045","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1472-8206.1998.tb00982.x","article-title":"Dextromethorphan and dextrorphan in rats: common antitussives\u2014different behavioural profiles","volume":"12","author":"Dematteis","year":"1998","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174218_bb0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fnmol.2017.00287","article-title":"Hyperactivity of Hypothalamic-Pituitary-Adrenal Axis Due to Dysfunction of the Hypothalamic Glucocorticoid Receptor in Sigma-1 Receptor Knockout Mice","volume":"10","author":"Di","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2026.174218_bb0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00008877-199402000-00004","article-title":"The effects of amphetamine, phencyclidine, dopaminergic antagonists and atypical neuroleptics on schedule-induced polydipsia (SIP) are distinguishable","volume":"5","author":"Didriksen","year":"1994","journal-title":"Behav. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.pbb.2026.174218_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2007.02.019","article-title":"Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine","volume":"563","author":"Egashira","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174218_bb0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/bs.irn.2022.10.002","article-title":"Sex differences and hormonal regulation of metabotropic glutamate receptor synaptic plasticity","volume":"168","author":"Fabian","year":"2023","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.pbb.2026.174218_bb0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jad.2019.11.136","article-title":"Comorbidity of obsessive-compulsive disorder in bipolar spectrum disorders: systematic review and meta-analysis of its prevalence","volume":"263","author":"Ferentinos","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pbb.2026.174218_bb0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jad.2006.04.019","article-title":"Clinical features associated to refractory obsessive-compulsive disorder","volume":"94","author":"Ferr\u00e3o","year":"2006","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pbb.2026.174218_bb0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004850-199603000-00003","article-title":"Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial","volume":"11","author":"Goodman","year":"1996","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pbb.2026.174218_bb0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pnpbp.2015.03.012","article-title":"A response strategy predicts acquisition of schedule-induced polydipsia in rats","volume":"61","author":"Gregory","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2026.174218_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/ph18030353","article-title":"The Efficacy of Fluvoxamine in Anxiety Disorders and Obsessive-Compulsive Disorder: An Overview of Systematic Reviews and Meta-Analyses","volume":"18","author":"Haddad","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.pbb.2026.174218_bb0095","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/npp.2009.29","article-title":"5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice","volume":"34","author":"Halberstadt","year":"2009","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.pbb.2026.174218_bb0100","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00213-013-3345-9","article-title":"The amphetamine sensitization model of schizophrenia symptoms and its effect on schedule-induced polydipsia in the rat","volume":"231","author":"Hawken","year":"2014","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.pbb.2026.174218_bb0105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1017\/S1461145710001604","article-title":"The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder","volume":"14","author":"Hesse","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2026.174218_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108064","article-title":"Effects of 5-HT2C receptor modulation and the NA reuptake inhibitor atomoxetine in tests of compulsive and impulsive behaviour","volume":"170","author":"Higgins","year":"2020","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2026.174218_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pbb.2003.09.020","article-title":"Acceleration of onset of action in schedule-induced polydipsia: combinations of SSRI and 5-HT1A and 5-HT1B receptor antagonists","volume":"77","author":"Hogg","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2026.174218_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2022.107635","article-title":"Dextromethorphan reduces sign-tracking but not goal-tracking in male Sprague-Dawley rats","volume":"192","author":"Holden","year":"2022","journal-title":"Neurobiol. Learn. Mem."},{"issue":"6","key":"10.1016\/j.pbb.2026.174218_bb0125","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4088\/JCP.v64n0604","article-title":"A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder","volume":"64","author":"Hollander","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174218_bb0130","first-page":"25","article-title":"The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases","author":"Ishikawa","year":"2009","journal-title":"J. Recept. Ligand Channel Res."},{"issue":"8","key":"10.1016\/j.pbb.2026.174218_bb0135","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.biopsych.2007.04.001","article-title":"High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C] SA4503","volume":"62","author":"Ishikawa","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2026.174218_bb0140","doi-asserted-by":"crossref","first-page":"21133","DOI":"10.4088\/JCP.14r09758","article-title":"Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis","volume":"77","author":"Issari","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174218_bb0150","series-title":"Sex differences in the genetic architecture of obsessive-compulsive disorder","first-page":"351","article-title":"Tourette Syndrome\/Obsessive-Compulsive Disorder Working Group of the Psychiatric Genomics Consortium","volume":"180","author":"Khramtsova","year":"2019"},{"issue":"20","key":"10.1016\/j.pbb.2026.174218_bb0155","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1111\/bph.12710","article-title":"Sex differences in animal models of psychiatric disorders","volume":"171","author":"Kokras","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174218_bb0160","article-title":"A review of the neuropharmacological profile of schedule-induced polydipsia","volume":"159","author":"Lalonde","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.pbb.2026.174218_bb0165","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.yhbeh.2005.05.019","article-title":"Differences in corticosterone level due to inter-food interval length: implications for schedule-induced polydipsia","volume":"49","author":"L\u00f3pez-Grancha","year":"2006","journal-title":"Horm. Behav."},{"issue":"3","key":"10.1016\/j.pbb.2026.174218_bb1020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00213-007-1059-6","article-title":"Individual differences in schedule-induced polydipsia and the role of gabaergic and dopaminergic systems","volume":"197","author":"L\u00f3pez-Grancha","year":"2008","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.pbb.2026.174218_bb1010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/FBP.0000000000000649","article-title":"Assessment of antidepressant-like effects of dextromethorphan on differential reinforcement of low-rate 72-s performance in rats","volume":"32","author":"Lynch","year":"2021","journal-title":"Behav. Pharmacol."},{"issue":"4","key":"10.1016\/j.pbb.2026.174218_bb0170","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0091-3057(01)00713-4","article-title":"Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety","volume":"71","author":"Martin","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pbb.2026.174218_bb0175","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-017-4819-y","article-title":"Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia","volume":"235","author":"Martin-Gonzalez","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2026.174218_bb0180","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1038\/s41380-023-02256-z","article-title":"The development of compulsive coping behavior depends on dorsolateral striatum dopamine-dependent mechanisms","volume":"28","author":"Marti-Prats","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"1-2","key":"10.1016\/j.pbb.2026.174218_bb1030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jnr.23809","article-title":"Understanding the broad influence of sex hormones and sex differences in the brain","volume":"95","author":"McEwen","year":"2017","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.pbb.2026.174218_bb0185","doi-asserted-by":"crossref","first-page":"609","DOI":"10.9758\/cpn.23.1081","article-title":"Dextromethorphan-bupropion (Auvelity) for the treatment of major depressive disorder","volume":"21","author":"McCarthy","year":"2023","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.pbb.2026.174218_bb0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pnpbp.2019.03.016","article-title":"Behavioral and biological markers for predicting compulsive-like drinking in schedule-induced polydipsia","volume":"93","author":"Merch\u00e1n","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174218_bb1035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.09.004","article-title":"Reduced cortical serotonin 5-HT2A receptor binding and glutamate activity in high compulsive drinker rats","volume":"143","author":"Mora","year":"2018","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.pbb.2026.174218_bb0195","first-page":"716","article-title":"The neurobiology of compulsive behavior: Role of the anterior insular cortex","volume":"23","author":"Moreno","year":"2012","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2026.174218_bb0200","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00213-011-2575-y","article-title":"Poor inhibitory control and neurochemical differences in high compulsive drinker rats selected by schedule-induced polydipsia","volume":"219","author":"Moreno","year":"2012","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pbb.2026.174218_bb0205","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00004714-199708000-00005","article-title":"Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study","volume":"17","author":"Mundo","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2026.174218_bb0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(96)00254-3","article-title":"Interactions of selective serotonin reuptake inhibitors with subtypes of \u03c3 receptors in rat brain","volume":"307","author":"Narita","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174218_bb0215","series-title":"Guide for the care and use of laboratory animals","first-page":"220","author":"National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.pbb.2026.174218_bb0220","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00213-014-3699-7","article-title":"Activation of serotonin 5-HT2A receptors inhibits high compulsive drinking on schedule-induced polydipsia","volume":"232","author":"Navarro","year":"2015","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pbb.2026.174218_bb0225","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FBP.0000000000000723","article-title":"Lack of sex and estrous stage effects on compulsive behavior assessed using a schedule-induced polydipsia procedure in rats","volume":"34","author":"Park-Oates","year":"2023","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2026.174218_bb0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/pcn.13760","article-title":"Serotonergic underpinnings of obsessive-compulsive disorder: a systematic review and meta-analysis of neuroimaging findings","volume":"79","author":"Pastre","year":"2025","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2026.174218_bb0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbr.2010.10.010","article-title":"Individual differences in schedule-induced polydipsia: neuroanatomical dopamine divergences","volume":"217","author":"Pell\u00f3n","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.pbb.2026.174218_bb0240","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1007\/s12035-023-03506-5","article-title":"Reduced expression of the Htr2a, Grin1, and Bdnf genes and cognitive inflexibility in a model of high compulsive rats","volume":"60","author":"Prados-Pardo","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.pbb.2026.174218_bb0245","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/FBP.0000000000000159","article-title":"The antidepressant drugs fluoxetine and duloxetine produce anxiolytic-like effects in a schedule-induced polydipsia paradigm in rats: enhancement of fluoxetine\u2019s effects by the alpha2 adrenoceptor antagonist yohimbine","volume":"26","author":"Prus","year":"2015","journal-title":"Behav. Pharmacol."},{"issue":"11","key":"10.1016\/j.pbb.2026.174218_bb0250","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/jwh.2022.0484","article-title":"Age-Dependent Sex Differences in the Prevalence of Selective Serotonin Reuptake Inhibitor Treatment: A Retrospective Cohort Analysis","volume":"32","author":"Sanchez-Ruiz","year":"2023","journal-title":"J. Women\u2019s Health"},{"issue":"1","key":"10.1016\/j.pbb.2026.174218_bb1015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3565(25)09485-6","article-title":"(1-(2, 5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A\/2C antagonists, D1 antagonists and 5-HT1A agonists","volume":"273","author":"Schreiber","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2026.174218_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.703701","article-title":"Comorbidities in obsessive-compulsive disorder across the lifespan: a systematic review and meta-analysis","volume":"12","author":"Sharma","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2026.174218_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.1997.tb00313.x","article-title":"Anti-obsessional and antidepressant profile of besipirdine","volume":"3","author":"Smith","year":"1997","journal-title":"CNS Drug Rev."},{"issue":"4","key":"10.1016\/j.pbb.2026.174218_bb0270","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41386-022-01522-y","article-title":"The development of compulsive coping behaviour is associated with a downregulation of Arc in a Locus Coeruleus neuronal ensemble","volume":"48","author":"Velazquez-Sanchez","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2026.174218_bb0275","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.expneurol.2007.06.013","article-title":"A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder","volume":"207","author":"Werling","year":"2007","journal-title":"Exp. Neurol."},{"issue":"2\u20133","key":"10.1016\/j.pbb.2026.174218_bb0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02244910","article-title":"Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder","volume":"112","author":"Woods","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2026.174218_bb0285","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","article-title":"The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder","volume":"100","author":"Wu","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2026.174218_bb0290","article-title":"Sense of happiness and other aspects of quality of life in patients with obsessive-compulsive disorder","volume":"13\u20132022","author":"\u017berdzi\u0144ski","year":"2022","journal-title":"Front. Psychol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726000730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726000730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:59:59Z","timestamp":1783742399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305726000730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":61,"alternative-id":["S0091305726000730"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174218","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of compulsive behavior by dextromethorphan on schedule-induced polydipsia in rats: Role of NMDA, sigma-1, and 5-HT receptors","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"174218"}}